Literature DB >> 23901336

A 12-year epidemiologic study on primary spinal cord tumors in Isfahan, Iran.

Payam Moein1, Omid Behnamfar, Nima Khalighinejad, Ziba Farajzadegan, Salman Abbasi Fard, Mostafa Razavi, Parvin Mahzouni.   

Abstract

BACKGROUND: Although primary spinal cord tumors (PSCTs) comprise a minority of primary central nervous system tumors, they often impose a great deal of morbidity on their victims. Few epidemiologic studies have addressed PSCTs in Iran.
MATERIALS AND METHODS: We analyzed the demographic/clinical features of all primary intraspinal tumors (with a specific focus on primary intradural spinal cord tumors) identified between 1992 and 2004 in three of the major related hospitals in Isfahan, Iran. We also tracked the malignant cases until 2012.
RESULTS: 102 patients with primary intraspinal tumors were found; 82 tumors were Intradural (36 intramedullary and 46 extramedullary) and 20 extradural. The principal intradural histological subtypes were nerve sheath tumor (33%), ependymoma (22%), astrocytoma (16%), and meningioma (15%). 20 (19%) of the tumors were malignant. Local pain (43%) and motor disabilities (36%) were the most common first-presenting symptoms in the patients. Male-to-female ratio was significant only in ependymoma (male:female ratio = 3.6, P < 0.05). The mean age in meningioma (57 years, standard error [SE]: 15.7) was significantly higher than other types (one-way ANOVA, P < 0.05).
CONCLUSION: Our results reflect analogous frequency of distribution for PSCTs compared with most of the previous counterpart studies worldwide. The only notable exception was the comparatively fewer frequency of spinal cord meningioma in our study.

Entities:  

Keywords:  Epidemiology; spinal cord neoplasms; survival rate

Year:  2013        PMID: 23901336      PMCID: PMC3719220     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


INTRODUCTION

Primary spinal cord tumors (PSCTs) are typically classified into two major groups: Extradural and intradural. Extradural ones usually arise from adjacent connective tissues. In contrast, intradural tumors originate from neural, glial, or meningial cells in the spinal cord and are subcategorized into intramedullary and extramedullary. PSCTs comprise only 4% of primary central nervous system (CNS) tumors. Regarding the rarity, little population-based studies are available for them.[1] Most of these studies lack uniform pathologic criteria and rarely include nonmalignant cases.[2] A solid fund of knowledge on the clinical and demographic features of each class of tumor can streamline the process of diagnosis and management, which ultimately improves the prognosis.[34] We conducted this epidemiologic study on primary intraspinal tumors in Isfahan to investigate their frequency, clinical presentations, current management, and outcome.

MATERIALS AND METHODS

Tumor registries of three major health care centers in Isfahan city (Al-Zahra, Kashani, and Sayed-Al-Shohada Hospitals) were explored for PSCT cases diagnosed during the period September 1992 through September 2004. The diagnosis had been established by biopsy subsequent to magnetic resonance imaging (with gadolinium-contrast). Patient demographic/clinical data (gender, age at onset, presenting symptoms) was collected using patients’ file and via phone interviews. The patients were categorized into four age groups: Children (0-19 years), younger adults (20-44 years), older adults (45-64 years), and seniors (≥65 years). Initial symptoms were categorized into four groups: Local pain (neck pain, thoracic back pain, low back pain); muscle weakness (decreased limb force); sensory dysfunction (paresthesia, sensory loss, impaired temperature, and vibration sensation); and referral pain (radicular limb pain, e.g., shoulder pain). Data on tumor characteristics and treatment modalities was also collected from the surgery/pathology notes in the patient file. The tumor histology groupings are largely consistent with the World Health Organization categories for CNS neoplasms.[5] Moreover, based on the tumor site in relation to the thecal sac, tumors were categorized into three classes: Intradural intramedullary, intradural extramedullary, and extradural. The tumors were also classified according to their anatomical location across the spinal canal to cervical, thoracic, lumbar, sacral, and filum terminalis. Malignant cases were contacted to follow the patient situation up until 2012. The SPSS release 16 (SPSS Science Inc., Chicago, IL, USA) was used for statistical analyses. The associations between categorical variables were assessed using Chi-square test (along with reporting χ2 values and degree of freedom given in parentheses). Binominal tests (test proportion: 50%) were employed to analyze the goodness-of-fit. One-way ANOVA with post-hoc test was used to compare one continuous variable amongst multiple categorical variables. Using binary logistic regression, the impact of different factors on the rate of malignancy was analyzed. The level of statistical significance was set at P < 0.05 (two-tailed) in all statistical analyses. Mean ± standard error (SE) of mean was reported where deemed to facilitate interpretation.

RESULTS

All tumors

102 patients (59 male and 43 female) with primary intraspinal tumors were found. The mean overall age at diagnosis was 40.2 (SE: 1.9). A summary of key findings on all cases in this study is presented in [Table 1]. Patient/tumor features by age groups are summarized in [Table 2]. The data on intradural tumors (intramedullary and extramedullary) are juxtaposed with those on extradural tumors in [Table 3]. Twenty out of 102 (19%) tumors were malignant.
Table 1

Characteristics by histology of 102 primary spinal cord tumors diagnosed in 1992-2004 in Isfahan, Iran

Table 2

Primary spinal cord tumor characteristics by age groups in 102 cases in Isfahan, Iran, 1992-2004

Table 3

Tumor characteristics by anatomical location in 102 primary spinal cord tumors diagnosed in Isfahan, Iran from 1992 to 2004

Characteristics by histology of 102 primary spinal cord tumors diagnosed in 1992-2004 in Isfahan, Iran Primary spinal cord tumor characteristics by age groups in 102 cases in Isfahan, Iran, 1992-2004 Tumor characteristics by anatomical location in 102 primary spinal cord tumors diagnosed in Isfahan, Iran from 1992 to 2004

Astrocytoma

All of the 16 astrocytomas (11 male, 6 female) were intramedullary. Eleven tumors were of low-grade (nine pilocytic astrocytoma, two diffuse fibrillary astrocytoma) and five of high-grade type (two anaplastic astrocytoma, three glioblastoma multiform). Five out of 16 tumors were malignant. Four of the five high-grade cases died within 5 years of diagnosis in the mean interval of 2.3 years from treatment. The mean overall radiation dose was 48.7 gray (Gy) (SE = 0.26), ranging from 24 to 58 Gy, at 1.4 Gy per fraction, in 5 weeks.

Ependymoma

Of 23 spinal cord ependymoma (18 male and 5 female), 13 cases were cellular ependymoma, and eight cases were mixopapillary ependymoma. Transcytic and anaplastic type ependymoma each comprised one tumor. About 90% of tumors were intradural intramedullary [Table 1]. Three of the 23 spinal cord ependymoma (13%) had recurred in the meantime of 4 years (SE = 1.7) from treatment. After 7 years from diagnosis, only one patient had died, who was the only (1/23) malignant case with the diagnosis of anaplastic type ependymoma. The mean interval between symptoms onset and diagnosis was 25.5 months (SE = 6.6). In the 20 patients who had undergone surgery, total to subtotal resection was the method used for tumor removal in 13 cases and partial resection for the rest. A significantly higher involvement of filum terminalis was seen in ependymomas in comparison to other intradural tumors (Pearson χ2 = 29.8 (4), P < 0.005). Six out of eight tumors in which filum terminalis was invaded were mixopaillary ependymoma. The average radiation dose was 50.9 Gy (SE = 0.80), ranging from 32 to 56 Gy, at 1.8 Gy per fraction.

Meningioma

All 15 cases of meningioma (nine female, six male) were benign. Except one case which was extradural, the others were intradural extramedullary. Surgical resection was the main mean of therapy (total to subtotal removal in 11 cases and partial resection in four patients).

Nerve sheath tumor

With 34 nerve sheath tumors (NST) (17 male and 17 female), NST made up 39% of all intradural tumors in our study. 25 schwanoma, 6 neurofibroma, and 3 malignant peripheral NST were the subtypes reported in biopsy. Four out of 34 cases were malignant, three of which were malignant peripheral NST and the other one was schwanoma. Seven out of 34 cases (20%) had recurred in the mean 4.3 months from treatment (SE = 1.8). Of those 22 who had surgery alone, only one had recurred, compared to six recurrences in the 10 patients with adjuvant radiotherapy. However, this might be attributable to the difference between their surgery results as in the former group almost all 22 subjects had total to subtotal resection, while in the latter group, surgery method was a partial removal in 8 of 10 patients. The average symptom onset-diagnosis time was 27.2 months (SE = 4.5). The mean radiation dose was 49 Gy (SE = 0.29), ranging from 30 to 60 Gy, at about 1.6 Gy in fraction.

Other

In the remaining 14 cases of primary intraspinal tumors, 13 (93%) were pure extradural, including a wide variety of histologies; three plasmacytomas, two lymphomas, two chordoma, two chondromas, one neuroblastoma, one meduloblastoma, one hemangioblastoma, a cavernous hemangioma, and one spinal cord squamous cell carcinoma. Tumors were widely distributed across the spinal canal, with some extending throughout the spine.

DISCUSSION

We evaluated 102 primary spinal cord tumors diagnosed during a 12-year period, in three of the major clinical centers in Isfahan, Iran (Al-Zahra, Kashani, and Sayed-Al-Shohada Hospitals). NSTs (33%) and ependymoma (22%) were the most frequent tumor types [Figure 1], like what was found in Chicago and Croatia.[67] Nevertheless, meningioma accounted for 15% of our tumors, contrasting with some other reports where it was one of the most common PSCTs.[678] The first presenting symptoms were local pain and muscular weakness, regardless of tumor pathology. This is consistent with the findings of a similar study in Chicago, 2010.[9] Considering the length of each anatomical division, all types of tumors showed an even distribution along the spinal canal (χ2 = 4.1 (3), P > 0.05).
Figure 1

Frequency distribution (number, percent) of primary spinal cord tumors by histological classification in 102 patients: Isfahan, Iran, 1992-2004 (number and percent of cases in each group is noted)

Frequency distribution (number, percent) of primary spinal cord tumors by histological classification in 102 patients: Isfahan, Iran, 1992-2004 (number and percent of cases in each group is noted) As presented in Table 1, the overall male-to-female rate ratio was 1.37 (binominal test, P = 0.137). The only statistically significant difference in the histological type between the genders was found for ependymoma (male:female ratio 3.6; P = 0.011). The male:female ratio imbalance was near-to-significant in children (binominal test; test proportion = 0.5, P = 0.077) with the predominance of males [Table 2]. The male:female ratio was 27/9 in intradural intramedullary tumors, significantly deferring from what was found in intradural extramedullary and extradural cases (Pearson χ2 = 6.7 (2), P = 0.034 [Table 3]). The mean age of subjects with meningioma was significantly higher than those with other tumor types (one-way ANOVA; f = 5.1, P = 0.001). A similar finding emerged from a later study in the US.[6] Both NSTs and ependymoma were more common in “younger adults” (32 in total [68%]) (P = 0.001). NST was also the predominant histology in “older adults” (11 [44%]) (χ2 = 11.2 (4), P = 0.024). In children (0-19 years, n = 20), however, ependymoma had the most frequency (n = 7) followed by astrocytoma (n = 6), nearly similar to other studies.[1011] Patients with intradural intramedullary tumors had a significantly lower mean age than those with intradural extramedullary and extradural tumors (one-way ANOVA, P = 0.012). The intradural intramedullary tumors were more common in children (62%) while the intradural extramedullary tumors revealed a higher frequency in older adults (64%) [Table 2]. Malignant tumors were observed more frequently in extradural compared to intradural tumors (Pearson χ2 = 21 (2), P = 0.005). In the intradural tumors, a higher malignancy rate was observed in astrocytomas compared to other histological subtypes (Pearson χ2 = 9.3 (3), P = 0.025 [Figure 2]). However, when binary logistic regression analysis was made, neither tumor histology nor tumor site did not have significant odds ratio in the predicting of malignancy rate (P > 0.05). This might have reached significance in the presence of a larger sample size. Gender, age, primary symptoms, and tumor location within spinal cord, did not show meaningful discrepancies between the malignant and non-malignant groups (Chi-square test, P > 0.05). Similar findings were reported in some of the previous studies.[1213]
Figure 2

102 primary spinal cord tumors in Isfahan, Iran, from 1992 to 2004. (a) Tumor location by malignancy in 102 primary spinal cord tumors. Extradural tumors showed a higher tendency toward malignancy than intradural tumors. (b) Tumor histology by malignancy in 88 primary intradural spinal cord tumors. Astrocytomas seemed more likely to be malignant than other types

102 primary spinal cord tumors in Isfahan, Iran, from 1992 to 2004. (a) Tumor location by malignancy in 102 primary spinal cord tumors. Extradural tumors showed a higher tendency toward malignancy than intradural tumors. (b) Tumor histology by malignancy in 88 primary intradural spinal cord tumors. Astrocytomas seemed more likely to be malignant than other types Several limitations were confronted in this study. Registries in Iran health institutes are not still fully computerized, which leads to underreporting of cases. Moreover, loss of definite biopsy-based diagnosis and lack of consensus on diagnostic criteria for particular subtypes that may result in misclassification.[14] Furthermore, the low incidence of spinal cord tumors and the referral of many patients from the external provinces to Isfahan prevented us from computing the incidence rate. Few epidemiologic studies have been done so far with a focus on both malignant and non-malignant primary spinal cord tumors. While previous studies often spared extradural tumors from analyses, we focused on all intradural and extradural primary spinal cord tumors. The descriptive and inferential analyses performed in this study can contribute to the epidemiologic knowledge of PSCTs in Iran.
  14 in total

Review 1.  Primary intramedullary tumors of the spinal cord.

Authors:  James S Harrop; Aruna Ganju; Michael Groff; Mark Bilsky
Journal:  Spine (Phila Pa 1976)       Date:  2009-10-15       Impact factor: 3.468

2.  Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution.

Authors:  Sergio Rosemberg; Dirce Fujiwara
Journal:  Childs Nerv Syst       Date:  2005-07-26       Impact factor: 1.475

3.  The incidence of primary intracranial neoplasms in Rochester, Minnesota, 1935-1977.

Authors:  L T Kurland; B S Schoenberg; J F Annegers; H Okazaki; C A Molgaard
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Intramedullary spinal cord astrocytoma in adults: postoperative outcome.

Authors:  M S Kim; C K Chung; G Choe; I H Kim; H J Kim
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

5.  Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients.

Authors:  A Helseth; S J Mørk
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

Review 6.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

7.  Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop.

Authors:  Elizabeth B Claus; May Abdel-Wahab; Peter C Burger; Herbert H Engelhard; David W Ellison; Nicholas Gaiano; David H Gutmann; Daniel A Heck; Eric C Holland; George I Jallo; Carol Kruchko; Larry E Kun; Bernard L Maria; Zoran Rumboldt; Daniela Seminara; Giovanna M Spinella; Linda Stophel; Robert Wechsler-Reya; Margaret Wrensch; Richard J Gilbertson
Journal:  J Neurosurg Spine       Date:  2010-02

8.  Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999.

Authors:  T B Johannesen; E Angell-Andersen; S Tretli; F Langmark; K Lote
Journal:  Neuroepidemiology       Date:  2004 May-Jun       Impact factor: 3.282

9.  International incidence of childhood brain and spinal tumours.

Authors:  C A Stiller; J Nectoux
Journal:  Int J Epidemiol       Date:  1994-06       Impact factor: 7.196

10.  The descriptive epidemiology of primary intracranial neoplasms: the Connecticut experience.

Authors:  B S Schoenberg; B W Christine; J P Whisnant
Journal:  Am J Epidemiol       Date:  1976-11       Impact factor: 4.897

View more
  3 in total

1.  Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.

Authors:  Narjes Mehrvar; Azim Mehrvar; Mohammad Esmaeil Akbari; Ibrahim Qaddoumi
Journal:  Childs Nerv Syst       Date:  2017-05-29       Impact factor: 1.475

2.  Evaluation of Surgically Treated Primary Spinal Cord Tumors in a Single Brazilian Institution: A Case Series Study of 104 Patients.

Authors:  Eustáquio C Santos Júnior; François Dantas; Antônio Carlos V Caires; Gustavo A Cariri; Marco Túlio D Reis; Ricardo V Botelho; Fernando Luiz R Dantas
Journal:  Cureus       Date:  2022-03-22

3.  Surgically Treated Primary Spinal Cord Neoplasms in Southeastern Nigeria.

Authors:  Mark Chukwunweike Chikani; Okwuoma Okwunodulu; Mathew Mesi; Wilfred C Mezue; Samuel C Ohaegbulam; Chika C Ndubuisi
Journal:  J Neurosci Rural Pract       Date:  2018 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.